Howard B. Chrisman, MD President and CEO at Northwestern Medicine | Official website
+ Pharmaceuticals
Patient Daily | Jul 21, 2025

Minimally invasive procedure at Northwestern Medicine aids women with uterine fibroids

Millions of women suffer from uterine fibroids, which can cause significant health issues. At Northwestern Medicine, a new procedure called transcervical fibroid ablation (TFA) is providing relief without the need for major surgery.

Cayce McConnell, 46, experienced heavy and painful periods that required iron infusions and affected her work life. After consulting with her doctor and undergoing an ultrasound, she was diagnosed with uterine fibroids. McConnell has a family history of the condition, as many of her aunts have had hysterectomies due to fibroids.

Uterine fibroids are common tumors that affect up to 80% of individuals with a uterus during their reproductive years. Dr. Alexander Lin from Northwestern Medicine Palos Hospital explained that these tumors can lead to abnormal bleeding, fertility problems, and pelvic pain.

While some choose hysterectomy for relief, McConnell sought alternatives to avoid major surgery. Dr. Lin introduced her to TFA, a minimally invasive procedure using radiofrequency energy to destroy fibroids without incisions.

Dr. Lin described TFA as utilizing RF energy to heat and break down the fibroid tumors during an outpatient procedure combining intrauterine ultrasound with radiofrequency technology. This approach offers rapid recovery and symptom relief within three months for about 90% of patients.

McConnell underwent TFA at Northwestern Medicine Palos Hospital, experiencing minimal downtime and significant symptom improvement within a month. She now shares her positive experience with others who might benefit from this treatment option.

Northwestern Medicine provides various treatments for uterine fibroids across its facilities in Chicago's south suburbs and beyond.

Organizations in this story